Tuesday, January 8, 2013

Otsuka Pharma's subsidiary (Nutrition and Sante) acquires Valpiform

Otsuka Pharmaceutical subsidiary Nutrition & Santé, engaged in the production and sale of functional foods and nutrition products, has acquired Valpiform which is engaged in the business of manufacturing and marketing gluten-free nutrition from the multinational dairy conglomerate, Lactalis.   More than 1% of Europeans suffer from celiac disease, the market for gluten-free products, made with soy, corn or rice flours, containing no wheat, is steadily growing.  By acquiring a pioneer of gluten- and allergen-free nutrition, Nutrition & Santé obtains an integrated organization for the development, production and sale of gluten-free products.


The acquisition was completed on December 28, 2012. Established in 1990, Valpiform is a pioneer and French leader in gluten-free and allergen-free nutrition. The company owns a state-of-the-art facility for manufacturing allergen-free food products. Approximately 40% of Valpiform sales are exported from France, with particularly strong markets in Italy and Benelux. Valpiform generates Euro 8.4 m in annual sales and has 48 employees.